ࡱ> y"<{bjbj.{{u+L[:0```9999999$;=>>9-`````9:$9$9$9` 9$9`9$9$9$9peU+D/$99+:0[:$9{>T5{>$9$9&{>J9d``$9`````99$9```[:````{>`````````? O:">404>: 1 "01;8FO :><?;5:B0FVW B0 <548:> - B5E=VG=8E 28<>3 4> ?@54<5BC 70:C?V2;V V:0@AL:V 70A>18 @V7=V - 70 :>4>< CPV 70  021:2015  33690000-3 01>@0B>@=V @50:B828 4;O 02B><0B8G=>3> 0=0;V70B>@0 70:@8B>3> B8?C ! 7/? 0720  024:20190720 ?@54<5BC 70:C?V24. 28<V@C$0AC- 20==OV;L- :VABL8@>1=8:152925;0=V=0<V=>B@0=AD5@070 (ALT) IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O 0;0=V=0<V=>B@0=AD5@078 (") /Alanine Aminotransferase acc. to IFCC (ALTL)HB500 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0252955030;L=0 0A?0@B0B0<V=>B@0=AD5@070 (AST) IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O 0A?0@B0B0<V=>B@0=AD5@078(!") /Aspartate Aminotransferase acc. to IFCC (ASTL)HB500 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0353362030;L=89 E>;5AB5@8= IVD, @5035=B"5AB 4;O 287=0G5==O 7030;L=>3> E>;5AB5@8=C /CHOL HiCo Gen.2, cobas c, Int.HB400 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0453590!5G>28=0 (Urea) IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>28=8/ 07>BC A5G>28=8 /(UREA)HB500 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0553586!5G>20 :8A;>B0 IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O A5G>2>W :8A;>B8 /UA2/Uric Acid ver.2 HB400 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0653462"@83;VF5@848 IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O B@83;VF5@84V2 /Triglycerides (TRIGL)HB250 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0753989030;L=89 1V;>: IVD, @5035=B"5AB 4;O 287=0G5==O 7030;L=>3> 2<VABC 1V;:C /TP2/Total Protein Gen.2 HB300 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=08528750;LFV9 (Ca2+) IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O :0;LFVN (300 B5ABV2) /Calcium Gen.2 (300 tests)HB300 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0953316;V:>78;L>20=89 35<>3;>1V= (HbA1c) IVD, @5035=B"5AB 4;O :V;L:VA=>3> 287=0G5==O 35<>3;>1V=C /Tina-quant Hemoglobin A1c Gen.3 HB150 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01054386"8@5>W4=89 3>@<>= ("") IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7"5AB-A8AB5<0 4;O 287=0G5==O B8@5>B@>?=>3> 3>@<>=C 2 35=.HB200 B5ABV241> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01154417V;L=89 B@89>4B8@>=V= IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> B@89>4BV>=V=C /FT3 Gen.3HB200 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01254413V;L=89 B8@>:A8= IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O =572'O70=>3> B8@>:A8=C, gen.IIIHB200 B5ABV241> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01358729"8@5>?5@>:A84070 0=B8BV;0 ("-", <V:@>A><0;L=V 0=B8BV;0) , =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 0=B8BV; 4> B8@5>?5@>:A84078, 25@. 3 /Anti-TPO Gen.3HB100 B5ABV231> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01454187$>;V:C;>AB8<C;N20;L=89 3>@<>= ($!) IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O D>;V:C;>AB8<C;NNG>3> 3>@<>=C / FSHHB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01554254NB5W=V7C20;L=89 3>@<>= IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O ;NB5W=V7CNG>3> 3>@<>=C / LHHB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01654004"@>?>=V= " IVD, =01V@, D;N>@5AF5=B=89 V<C=>0=0;V7"5AB 4;O :V;L:VA=>3> 287=0G5==O A5@45G=>3> B@>?>=V=C ", 25@.2, 100 B5ABV2 HB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01754335@>;0:B8= IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7"5AB 4;O :V;L:VA=>3> 287=0G5==O ?@>;0:B8=C /Prolactin HB100 B5ABV231> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0185413953V4@>5?V0=4@>AB5@>= AC;LD0B (DHEAS) IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O 287=0G5==O 453V4@>5?V0=4@>AB5@>=-AC;LD0BC /DHEA-SHB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=01954588 0:>289 0=B835= 125 (!125) IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 "5AB 4;O 287=0G5==O @0:>2>3> 0=B835=C 125 IIHB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02054670V;L=89 (=572'O7=89) ?@>AB0B8G=89 A?5F8DVG=89 0=B835= (!) IVD, =01V@, V<C=>D;N>@5AF5=B=89 0=0;V7 01V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA)HB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02154665030;L=89 ?@>AB0B8G=89 A?5F8DVG=89 0=B835= (!) IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 01V@ @5035=BV2 Elecsys 4;O :V;L:VA=>3> 287=0G5==O :>=F5=B@0FVW 7030;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (Total PSA)HB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02256656V;>: 4 5?V4848<VA0 ;N48=8 (HE4) IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7 <C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O HE4HB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02348323V@CA 35?0B8BC B ?>25@E=5289 0=B835= IVD, @5035=B01V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O ?>25@E=52>3> 0=B835=C 2V@CAC 35?0B8BC B II (HBsAg II)HB100 B5ABV211> 5:2V20;5=B & ( * , . V X ƵnZL:("h/hS:5CJ\aJmHsH"h>7hS:5CJ\aJmHsHh/hS:5CJ\aJ'h,-h5CJOJQJaJmH"sH"'h>7h>75CJOJQJaJmH"sH"!h>75CJOJQJaJmH"sH"!hl5CJOJQJaJmH"sH"!h5CJOJQJaJmH"sH"!h,-5CJOJQJaJmH"sH"'h,-h,-5CJOJQJaJmH"sH"$h,-hLCJOJQJaJmH"sH"$h,-h,-CJOJQJaJmH"sH"( * , $ : R j | ~ FfA $Ifgd9 $$Ifa$gd9$V$If^Va$gd9 $da$gd,-$a$gd,- " j z | ~ f z b t v n&(028@JLNRX\| X$ôhhS:CJaJh/hS:CJaJh/hS:CJaJmHsH"h/hS:5CJ\aJmHsHhS:5CJ\aJmHsHh/hS:5CJ\aJhS:hS:5CJ\aJ> h j n z prv\bx| Ff FfK $Ifgd9Ff $$Ifa$gd9X`f|"VFfFfU $Ifgd9 $$Ifa$gd9hn*b  $BFfiFf $Ifgd9Ff_ $$Ifa$gd9 r.@DHNTt :@ H J P R X ^ ~ !!H"N"P"p""#$$$<$$D%%%&'`'r'z''(((R)Z)\)^)`))**+ ++.+++J,P,hhS:CJaJh/hS:CJaJh/hS:CJaJmHsHV&tv|028DTZptFfs$Ff $$Ifa$gd9 $Ifgd9  6:X^ d z ~ !!!"!!Ff/Ff}+ $Ifgd9Ff' $$Ifa$gd9!P"V"l"p""#####$"$8$<$Z$$$$$D%%%%%&&Ff 6Ff2 $$Ifa$gd9 $Ifgd9&&&&'z'''''*(,(2(>((`)f)|)))***$**+Ff@Ff= $Ifgd9 $$Ifa$gd9Ff9++*+.+L+++++,d-j----...(..//// 0|0FfG $Ifgd9Ff D $$Ifa$gd9P,,,P-X-Z-`-d--.(...////////z0*1t1x1|11*2@2^2`22222P3R3T3X3\3f3h3l3p333PpPtP"QBQPQQQQQQQQQRRRʷʷʷʷʷʨhhS:CJOJQJaJ$h/hS:CJOJQJaJmHsHh/hS:CJOJQJaJUhhS:CJaJh/hS:CJaJh/hS:CJaJmHsH>|0~000*1|11111,2.242@22p3v3333rPtPzPP"QQFf4RFfN $Ifgd9 $$Ifa$gd9Ff*KRoche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02448366V@CA 35?0B8BC C 7030;L=V 0=B8BV;0 IVD, =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V701V@ @5035=BV2 Elecsys 4;O O:VA=>3> 287=0G5==O 0=B8BV; 4> 2V@CAC 35?0B8BC ! (Anti-HCV II)=01V@100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02560922'8A;5=V D>@<8 25-384@>:A828B0<8=0 D , =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O 7030;L=>3> 25-3V4@>:A82VB0<V=C D 4;O A8AB5< cobas e, 100 HBHB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02660976 0:>289 0=B835= 19-9 (CA19-9) , =01V@, V<C=>E5<V;N<V=5AF5=B=89 0=0;V7<C=>B5AB 4;O :V;L:VA=>3> 287=0G5==O CA 19-9 /CA 19-9HB100 B5ABV211> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02738255$>;V:C;>AB8<C;NNG89 3>@<>= IVD, :0;i1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC FSH /FSH CalSet II=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02838270NB5W=V7CNG89 3>@<>= IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 0=0;V7C Elecsys LH /LH CS Gen.2=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=02938183V;L=89 (=572'O70=89) ?@>AB0B8G=89 A?5F8DVG=89 0=B835= (!) IVD, :0;i1@0B>@0;V1@C20;L=89 =01V@ 4;O :V;L:VA=>3> 287=0G5==O 2V;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C (free PSA)=01V@4 x 1.0 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03038208030;L=89 ?@>AB0B8G=89 A?5F8DVG=89 0=B835= (!) IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ Elecsys 4;O :V;L:VA=>3> 287=0G5==O :>=F5=B@0FVW 7030;L=>3> ?@>AB0B>A?5F8DVG=>3> 0=B835=C II (Total PSA II)=01V@4 x 1.0 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03153777030;L=89 V<C=>3;>1C;V=  (7030;L=89 IgE) IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC IgE=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03242091=AC;V= IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC Insulin=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03356658V;>: 4 5?V4848<VA0 ;N48=8 (HE4) IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC HE4=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0 3438231 0:>289 0=B835= 125 (!125) IVD, :0;i1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC 4;O 287=0G5==O @0:>2>3> 0=B835=C 125 II=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03554005"@>?>=V= " IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC Troponin T hs STAT=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03654474=>68==0 D>@<0 25-3V4@>:A8 2VB0<V=C D IVD, :0;V1@0B>@0;V1@C20;L=89 =01V@ 4;O V<C=>B5ABC Vitamin D total G2, 4 x 1.0 <;=01V@4 x 1<; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03738225 0:>289 0=B835= 19-9 (!19-9) IVD, :0;i1@0B>@0;V1@C20;L=89 =01V@ 4;O B5ABC CA 19-9=01V@4 x 1 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=03858236CD5@=89 ?@><820==O B0 @>7G8= , 02B><0B8G=V / =0?V202B><0B8G=V A8AB5<8@><82=89 @>7G8= NaOHD 4;O ?@>1 @5035=BC B0/01> @50:FV9=8E :0<5@ 2 A8AB5<0E Roche/Hitachi cobas c HB58,7 <; (ml)11> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=039590588NG89 / >G8ICNG89 @>7G8= , 4;O 02B><0B87>20=8E / ?>;C02B><0BV7V20==8E A8AB5<!8AB5<=89 @>7G8= 4;O G8AB:8 45B5:B>@=>3> 1;>:C, Elecsys, cobas e=01V@6 E 380 <; (ml)21> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=04058236CD5@=89 ?@><820==O B0 @>7G8= , 02B><0B8G=V / =0?V202B><0B8G=V A8AB5<8!8AB5<=89 @>7G8= 4;O 35=5@0FVW 5;5:B@>EV<VG=8E A83=0;V2 2 V<C=>0=0;V70B>@0E Elecsys, cobas e=01V@6 E 380 <; (ml)21> 5:2V20;5=B Roche Diagnostics GmbH, $545@0B82=0 5A?C1;i:0 V<5GG8=0 (  1.#G0A=8:8 ?>28==V =040B8 C A:;04V ?@>?>78FVW :>?VW 4>:C<5=BV2: !5@B8DV:0BC 01> ?0A?>@BC O:>ABV,01> 45:;0@0FVW ?@> 2V4?>2V4=VABL 7 4>40B:0<8. 2. "5E=VG=V, O:VA=V E0@0:B5@8AB8:8 ?@54<5B0 70:C?V2;V ?>28==V 2V4?>2V40B8 2AB0=>2;5=8</70@5TAB@>20=8< =>@<0B82=8< 0:B0< 4VNG>3> 70:>=>402AB20 (45@602=8< AB0=40@B0< 30@<>=V7>20=8< 7 T2@>?59AL:8<8 (B5E=VG=8< C<>20<)), O:V ?5@5410G0NBL 70AB>AC20==O 70E>4V2 V7 70E8ABC 4>2:V;;O. 3. # @07V ?>40==O ?@>?>78FVW, O:0 =5 2V4?>2V40T B5E=VG=8< 28<>30<, ?@>?>78FVO 1C45 2V4E8;5=0 O: B0:0, I> =5 2V4?>2V40T <548:>  B5E=VG=8< 28<>30<. 4. >6=0 ?0@BVO B>20@C <0T AC?@>2>46C20B8AL 4>:C<5=B0<8, I> ?V4B25@46CNBL O:VABL. 5. ">20@ ?>28=5= 715@V30B8AO C =0;56=8E C<>20E 2V4?>2V4=> 4> 2AB0=>2;5=8E 28@>1=8:>< =>@< B0 ?@028; 715@V30==O. 6. 0;8H:>289 AB@>: ?@840B=>ABV 70?@>?>=>20=>3> ?@54<5BC 70:C?V2;V =0 <><5=B ?>AB02:8 ?>28=5= AB0=>28B8 =5 <5=H5 85% 2V4 7030;L=>3> AB@>:C ?@840B=>ABV. 7. #G0A=8:8 =040NBL ;8AB0 2 4>2V;L=V9 D>@<V , O:8< ?V4B25@46CNBL <>6;82VABL ?>AB02:8 C :V;L:>ABV B0 O:>ABV 73V4=> <548:> - B5E=VG=8E 28<>3. 28@>1=8:0 (O:I> CG0A=8: =5 T 28@>1=8:><) 01> >@83V=0; ;8AB0 2V4 C?>2=>2065=>3> ?@54AB02=8:0 28@>1=8:0 (O:I> ?>AB0G0;L=8: =5 T 28@>1=8:>< 01> C?>2=>2065=8< ?@54AB02=8:>< 28@>1=8:0), C O:><C ?>28==> 1CB8 707=0G5=>, I> CG0A=8: B>@3V2 <0T 4>3>2V@=V 2V4=>A8=8 7 28@>1=8:>< 01> 2V4?>2V4=> 7 C?>2=>2065=8< ?@54AB02=8:>< 28@>1=8:0 B0 <0T <>6;82VABL ?>AB028B8 B>20@ C =5>1EV4=V9 :V;L:>ABV, =0;56=>W O:>ABV B0 C 287=0G5=V B5=45@=>N 4>:C<5=B0FVTN V ?@>?>78FVTN CG0A=8:0 AB@>:8 (=040T ?5@5<>65FL). QQQQRRRRR@STTT"T@TTTTTXUUUFf>Y $$Ifa$gd9d$Ifgd9$d$Ifa$gd9FfU $Ifgd9 $$Ifa$gd9RRRRR>S@STT"TTTTTTTTVUXUUUUrVtVvVxVzVnW긟whwO긟whwO0h/hS:CJOJPJQJaJmH"nH"sH"tH"hhS:CJOJQJaJh:(hS:CJOJQJaJ0h:(hS:CJOJPJQJaJmH"nH"sH"tH"0hhS:CJOJPJQJaJmH"nH"sH"tH"0hG}hS:CJOJPJQJaJmH"nH"sH"tH"0h/hS:CJOJPJQJaJmH"nH"sH"tH"*hS:CJOJPJQJaJmH"nH"sH"tH"UUUVtVvV|VVVBWNWjWnWWWXXX\XXXYFf<`d$Ifgd9$d$Ifa$gd9Ff\ $Ifgd9 $$Ifa$gd9 $$Ifa$gd9nWWWXXYYYYYD[[[[[](^*^,^0^$_____r`aaaaazb|b~bbc0d2d4d8d eeeeeeeeεεεεεεεεΆ0h/hS:CJOJPJQJaJmH"nH"sH"tH"*hS:CJOJPJQJaJmH"nH"sH"tH"0h/hS:CJOJPJQJaJmH"nH"sH"tH"0hG}hS:CJOJPJQJaJmH"nH"sH"tH"0hhS:CJOJPJQJaJmH"nH"sH"tH"/YY0YYYYYPZ[ [@[D[b[[[[[j\j]v]]]]*^,^FfjFfFgFfcd$Ifgd9$d$Ifa$gd9,^2^>^^^_ _$_B______F`R`n`r``aa aaxaaFfqFfPnd$Ifgd9$d$Ifa$gd9aaaab|b~bbbbvccccc2d4d:dFd|ddde e*eFfxFfZu$d$Ifa$gd9d$Ifgd9*eeeeeffffff\g^gdgpggh&hBhFhdhhFf $$Ifa$gd9 $$Ifa$gd9 $Ifgd9$d$Ifa$gd9Ffd|d$Ifgd9effdfrftfvfxffffffffZg\g^gbgdgngpggg hhhFhhhhhhλ··tthYh9hS:CJaJmH"sH"h9CJaJmH"sH"$h:(hS:CJOJQJaJmHsH*hS:CJOJPJQJaJmH"nH"sH"tH"hhS:CJOJQJaJh:(hS:CJOJQJaJ$h:(hS:CJOJQJaJmH"sH"0h/hS:CJOJPJQJaJmH"nH"sH"tH"0hhS:CJOJPJQJaJmH"nH"sH"tH" hhhh~iBjDjJjdjhjjjjk kk0lj@jBjDjhjjjjjjjjjjjjk kll l*l,l.l0l`l|l~llllllllllllmλ񨙍~񨙍~h9hS:CJaJmH"sH"h9CJaJmH"sH"h/NhS:CJaJmH"sH"$h/NhS:CJOJQJaJmH"sH"$hS:hS:CJOJQJaJmH"sH"hS:CJOJQJaJmH"sH"$h/NhS:CJOJQJaJmHsHh/NhS:CJOJQJaJ1llmmRn^n~nnnooo.ooLpNptrsBt;^;gdK ;^;gdK $;^;a$gdK $;^;a$gd/NFf $$Ifa$$If $IfgdK $$Ifa$ $$Ifa$gd}0mmnnnnnnnnnnoooooooJpLpbssvnw<{˻ˬyyhKCJaJmH"sH"hCJaJmH"sH"hKhKCJaJmH"sH"hTUCJaJmH"sH"hhS:CJaJmH"sH"hS:CJOJQJaJmH"sH"$hhS:CJOJQJaJmH"sH"h/NhS:CJOJQJaJ$h/NhS:CJOJQJaJmHsHBt"uRv<{;^;gdK,1h. A!"R#R$R% ?$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lW t0*575535j 55S5R5j 9BapPyt96kd$$IflWִV7j Y&F7FF3fj FFSFRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdy$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$Ifl ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd $$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lF t0*575535j 55S5R5j 999BapPyt96kd&#$$IflFִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lF t0*575535j 55S5R5j 999BapPyt96kd&$$IflFִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lF t0*575535j 55S5R5j 999BapPyt96kd0*$$IflFִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd-$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l' t0*575535j 55S5R5j 999BapPyt96kd:1$$Ifl'ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lF t0*575535j 55S5R5j 999BapPyt96kd4$$IflFִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdD8$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V le t0*575535j 55S5R5j 999BapPyt96kd;$$IfleִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdN?$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l' t0*575535j 55S5R5j 999BapPyt96kdB$$Ifl'ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdXF$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdI$$IflִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l' t0*575535j 55S5R5j 999BapPyt96kdbM$$Ifl'ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l0 t0*575535j 55S5R5j 999BapPyt96kdP$$Ifl0ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l' t0*575535j 55S5R5j 999BapPyt96kdlT$$Ifl'ִV7j Y&f7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*,575535j 55S5R5j 999apPyt90kdW$$IflִV7j Y&&7&3j &S&Rj t0*    44 lapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*,575535j 55S5R5j 999apPyt90kdp[$$IflִV7j Y&&7&3j &S&Rj t0*    44 lapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd^$$IflִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdtb$$IflִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l' t0*575535j 55S5R5j 999BapPyt96kde$$Ifl'ִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kd~i$$IflִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V le t0*575535j 55S5R5j 999BapPyt96kdm$$IfleִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*575535j 55S5R5j 999BapPyt96kdp$$IflִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V le t0*575535j 55S5R5j 999BapPyt96kd t$$IfleִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lf t0*575535j 55S5R5j 999BapPyt96kdw$$IflfִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lf t0*575535j 55S5R5j 999BapPyt96kd{$$IflfִV7j Y&&7fF3Fj fFSfRFj t0*    44 lBapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lf t0*,575535j 55S5R5j 999apPyt90kd~$$IflfִV7j Y&&7&3j &S&Rj t0*    44 lapPyt9K$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lf t0*,575535j 55S5R5j 999apPyt90kd$$IflfִV7j Y&&7&3j &S&Rj t0*    44 lapPyt9W$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V lL t0*,,575535j 55S5R5j 999BapPyt96kd$$IflLִV7j Y&f7&3j &S&Rj t0*    44 lBapPyt9W$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*,,575535j 55S5R5j 999BapPyt96kd+$$IflִV7j Y&f7&3j &S&Rj t0*    44 lBapPyt9]$$If!vh#v7#v#v3#vj #v#vS#vR#vj :V l t0*,,,575535j 55S5R5j 999BapPyt96kd$$IflִV7j Y&f7&3j &S&Rj t0*    44 lBapPyt9j 666666666vvvvvvvvv666666>6666666666666666666666666666666666666666666666666hH6666666666666666666666666666666666666666666666666666666666666666662 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH"nH"sH"tH"L`L 1KG=K9 dCJ_HaJmH sH tH BA B A=>2=>9 H@8DB 0170F0Xi@X 01KG=0O B01;8F04 l4a .k . 0 5B A?8A:0 pp ,- !5B:0 B01;8FK7:V0PK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭VCWNIA!ޝ}7/݉%BR7Hw9!p<Ǥፉ.EB\ /T*Y>,cy'$gC."Vso+C1OǓt}8>V3mBb%DWs'O''Gw ~lh;UM!DzŬ;C K^ysJJ1KRμ)~.ک/ Y\n9?[]67)qnpJOF$ w;fCLL&׸m%]V%z-{ v8Ҩm-.xo(-ms~ۜ|s>Ͼ%O04h=یщ!eƌ\f :C*OiIA 64HpUa7 UO3 d:(fA@٣>N"Hhp&hA38 )SUUR'V5&HM.6xpyn,ބ!h^^Z4~0#w,,& g"Ic힍Q)˕C6%^+Hk!$A*#.D)irdq8Y^}q~C>Np%uJx?+al|zf[Ux5b>c!:M (MkIVEpYPҍN2$ÿ -.h۴"P6T{T 6]u̒VhVnR+n;)ȔbL X6Y`+qB]( 0H1$6_[s)k8Tm Aa?R d ڒɾ0{eRF& Ī't\{BHuM6`pGϽO+!XoN'^[crh2*tW<{1U+l_QSncX<)Q(wJH ٯ#zCm>nhf6t}M&ʺ6ײ'\gkNS:;\qN-S;kǺ"{DailL`̗/޿ ^o#I&%0]SPV!] PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!^}-theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] u+ P,RnWehm<{ &?AFHJ !&+|0QUY,^a*ehlBt<{!"#$%'>@BCDEGIK8@0(  B S  ?  !#()-/45=G]ipquvyz)*3=EF^{"#-.7AJKU[blvw$+5@AKLT\dmotz}  027=@CDNgrs}~'23=>GQZ[`fmnrsvw )01569:EFPRY_e'(24?bdioruv   " @ B G M P S T ^ w      * , 1 7 : = > H a l m w x     ! + D O P Z [ d o     / 1 6 < ? B C M f q r | }    ( * / 5 8 ; < F _ j k u v  !",EPQ[\epx $/0:;DOX^ce|}  45<JOQhiopy~!38:QRXcm  */1DEKMRS\]ditu *+6JOQhioqvw()34=HMP[\bnsu   %1<RWXabinvw (+34<BGI`aghmnwx (/Xow%&/d{.;Ejmnt29>@VXZ\otu8LW[oqsu !(\p~%/OR_acex}~  $%015CMju @J  4 < ? A S U W Y l q r } ~ !%!'!(!-!=!@!A!K!d!o!p!z!{!!!!!!!!!!!!!!!"!","-"7"8"A"L"T"U"_"c"i"o"z"}""""""""""""""""""##>#H#]#c#f#o#p#v#################:$D$Y$a$b$l$p$v$|$$$$$$$$$$$$$$$$$$$$$$$$%%%%K%U%}))w+ QR14 nv./QRNOuvVW!"'(vw1349:EFwx}~IJOP]^no`afgvw  /0RSXYfgwx WY[\abJK  F G L M Z [ k l '!!!!!!!!!C"E" ##T#V###$$P$R$%&%b%m%n%%%%%''''''g(h(()t+w+ q5=9c,m0OIn 1b@ _ * I , f o / N ( G -gp FO  ?H (1:FxJoaSxYb G l (!L!!!! "C"L""#T#]##$P$Y$%'%w+1MZ,L`m:(,->7S:L/NTUG}=~K9/Gjl}0u+w+@})})})})(u+pppPUnknownG*Ax Times New Roman5Symbol3. *Cx Arial7.@ CalibriA$BCambria Math"qHc'jG6!!R20_+_+ KqHX  $P,-2!xx buh02buh02Oh+'0X    ,8@HPbuh02 Normal.dotmbuh025Microsoft Office Word@0@@*D՜.+,0 hp|  !_+     !"#$%&'()*+,-./0123456789:;<=>?@ABCDEFGHIJKLNOPQRSTUVWXYZ[\]^_`abcdefghijklmnopqrstuvwxyz{|}~Root Entry F%j+DData MS1Table{>WordDocument.SummaryInformation(DocumentSummaryInformation8CompObjr  F Microsoft Word 97-2003 MSWordDocWord.Document.89q